Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

[1]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[2]  V. V. van Hinsbergh,et al.  Role of endothelial cells and their products in the modification of low-density lipoproteins. , 1986, Biochimica et biophysica acta.

[3]  T. Funahashi,et al.  Effects of probucol on xanthomata regression in familial hypercholesterolemia. , 1986, The American journal of cardiology.

[4]  H. Waldmann,et al.  Monocytic origin of foam cells in human atherosclerotic plaques. , 1984, Atherosclerosis.

[5]  J. Witztum,et al.  Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[8]  D. Steinberg,et al.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Mahley,et al.  Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. , 1979, The Journal of clinical investigation.

[10]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Steinberg,et al.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[14]  D. Steinberg,et al.  Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.

[15]  S. Young,et al.  Probucol inhibits oxidative modification of low density lipoprotein. , 1986, The Journal of clinical investigation.

[16]  J. Witztum,et al.  Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein. , 1983, The Journal of clinical investigation.

[17]  M. Territo,et al.  Monocyte Chemotactic Factor Produced by Large Vessel Endothelial Cells in Vitro , 1986, Arteriosclerosis.

[18]  R. Goldberg,et al.  Probucol enhances cholesterol efflux from cultured human skin fibroblasts. , 1988, The American journal of cardiology.

[19]  V. V. van Hinsbergh,et al.  In vivo catabolism of biologically modified LDL. , 1984, Arteriosclerosis.

[20]  D. Steinberg,et al.  Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Steinberg,et al.  Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Nikkari,et al.  The effect of proteoglycans, collagen and lysyl oxidase on the metabolism of low density lipoprotein by macrophages. , 1986, Atherosclerosis.

[24]  D. Falcone,et al.  Fibronectin Stimulates Macrophage Uptake of Low Density Lipoprotein‐Heparin‐Collagen Complexes , 1988, Arteriosclerosis.

[25]  D. Steinberg,et al.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Chait,et al.  Human arterial wall cells secrete factors that are chemotactic for monocytes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Attie,et al.  Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Steinberg,et al.  Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.

[29]  A. J. Valente,et al.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. , 1988, Biochemistry.

[30]  B. Clevidence,et al.  Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortas. , 1984, Arteriosclerosis.

[31]  D. Parums,et al.  Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques. , 1981, Atherosclerosis.

[32]  M. Brown,et al.  Stimulation of Cholesteryl Ester Synthesis in Macrophages by Extracts of Atherosclerotic Human Aortas and Complexes of Albumin/Cholesteryl Esters , 1981, Arteriosclerosis.

[33]  M. Haberland,et al.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.

[34]  M. Reidy,et al.  Scanning electron microscopy in the evaluation of endothelial integrity of the fatty lesion in atherosclerosis. , 1976, Atherosclerosis.

[35]  S. Parthasarathy.  Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. , 1987, Biochimica et biophysica acta.

[36]  Y. Beck,et al.  Human Mn superoxide dismutase cDNA sequence. , 1987, Nucleic acids research.

[37]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[38]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[39]  T. Henriksen,et al.  Injury to human endothelial cells in culture induced by low density lipoproteins. , 1979, Scandinavian journal of clinical and laboratory investigation.

[40]  A. Chait,et al.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. , 1984, The Journal of clinical investigation.

[41]  S. Yokoyama,et al.  Probucol prevents lipid storage in macrophages. , 1986, Atherosclerosis.

[42]  U. Steinbrecher.  Role of superoxide in endothelial-cell modification of low-density lipoproteins. , 1988, Biochimica et biophysica acta.

[43]  O. Stein,et al.  Bovine aortic endothelial cells display macrophage-like properties towards acetylated 125I-labelled low density lipoprotein. , 1980, Biochimica et biophysica acta.

[44]  G. Camejo,et al.  Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. , 1987, Atherosclerosis.

[45]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[46]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Steinberg,et al.  Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.

[48]  G. Chisolm,et al.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.

[49]  J. Piper,et al.  Essential familial hypercholesterolemia and xanthomatosis; follow-up study of twelve Danish families. , 1956, The American journal of medicine.

[50]  R. Wissler,et al.  Progression and regression of atherosclerotic lesions. , 1978, Advances in experimental medicine and biology.

[51]  L. Simons,et al.  The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form. , 1975, Atherosclerosis.

[52]  J L Witztum,et al.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Kita,et al.  Cellular Pathology of Progressive Atherosclerosis in the WHHL Rabbit: An Animal Model of Familial Hypercholesterolemia , 1983, Arteriosclerosis.

[54]  M. Brown,et al.  Receptor-mediated control of cholesterol metabolism. , 1976, Science.

[55]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[56]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Morel,et al.  Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation , 1984, Arteriosclerosis.

[58]  A. Chait,et al.  Superoxide initiates oxidation of low density lipoprotein by human monocytes. , 1987, Arteriosclerosis.

[59]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[60]  D. Steinberg,et al.  Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[61]  B. Ames,et al.  Antioxidant defenses and lipid peroxidation in human blood plasma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Steinberg.  Lipoproteins and atherosclerosis. A look back and a look ahead. , 1983, Arteriosclerosis.

[63]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.